HeadInvest LLC’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $402K | Sell |
4,846
-36
| -0.7% | -$2.99K | 0.09% | 159 |
|
|
2025
Q1 | $396K | Sell |
4,882
-115
| -2% | -$9.33K | 0.08% | 167 |
|
|
2024
Q4 | $450K | Buy |
4,997
+235
| +5% | +$21.2K | 0.08% | 156 |
|
|
2024
Q3 | $470K | Buy |
4,762
+362
| +8% | +$35.8K | 0.09% | 156 |
|
|
2024
Q2 | $408K | Buy |
4,400
+685
| +18% | +$63.5K | 0.08% | 161 |
|
|
2024
Q1 | $353K | Buy |
+3,715
| New | +$353K | 0.07% | 173 |
|
|
2023
Q4 | – | Sell |
-1,203
| Closed | -$85K | – | 715 |
|
|
2023
Q3 | $85K | Buy |
+1,203
| New | +$85K | 0.02% | 299 |
|